NUVA
Nuvasive Inc (NUVA)
$50.80.71%▲
Key Stats
$50.36
Day's Range
$51.055
$45.45
52-Week Range
$64.43
| Returns | |
| 1 month return | 0.34% |
| 3 month return | 4.88% |
| 1 year return | 13.97% |
| 5 year return | 13.69% |
Company Information
NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
| Organization | Nuvasive Inc |
| Employees | 2700 |
| CEO | J. Christopher Barry |
| Industry | Health Technology |
Analyst Recommendation
based on 22 analysts ratings
Buy
59%
Buy
36%
Hold
4%
Sell
Based on 22 Wall street analysts offering stock ratings for Nuvasive Inc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 23.51%Current
$50.44
Target
$62.3
Recommendation Trend
Based on 22 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 13 | 13 | 14 |
| Hold | 8 | 8 | 8 |
| Sell | 1 | 1 | 2 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 2.7B |
| Book Value | 15.88 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0 |
| Earnings Share | -0.72 |
| PEG Ratio | 1.14 |
| Wall Street Target Price | 61.0 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 25.06 |
| Price/Sales (ttm) | 2.3 |
| Price/Book (mrq) | 3.31 |
| Enterprise Value | 3.5B |
| Enterprise Value/Revenue | 3.0 |
| Enterprise Value/Ebitda | 26.75 |
Technicals
| Beta | 1.14 |
| 50 Day MA | 50.89 |
| 200 Day MA | 52.9 |
Institutional Holdings
BlackRock Inc
11.56%
Vanguard Group Inc
9.7%
JPMorgan Chase & Co
5.91%
Thrivent Financial For Lutherans
3.91%
Macquarie Group Ltd
3.9%
Bank of America Corp
3.88%
